Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,539
  • Shares Outstanding, K 78,686
  • Annual Sales, $ 310 K
  • Annual Income, $ -30,270 K
  • 60-Month Beta 1.38
  • Price/Sales 88.11
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade VNRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings $-0.11 on 11/14/23
  • Latest Earnings Date 03/20/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 402.14% ( +6.55%)
  • Historical Volatility 96.35%
  • IV Percentile 67%
  • IV Rank 34.09%
  • IV High 1,013.43% on 12/28/23
  • IV Low 86.01% on 04/05/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 34
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,372
  • Open Int (30-Day) 1,343

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +768,561.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8633 +1.03%
on 03/05/24
1.1000 -20.71%
on 03/11/24
-0.1678 (-16.13%)
since 02/16/24
3-Month
0.6135 +42.17%
on 12/28/23
1.2300 -29.09%
on 02/06/24
+0.1122 (+14.76%)
since 12/18/23
52-Week
0.5500 +58.58%
on 12/13/23
2.1000 -58.47%
on 05/03/23
-0.9078 (-51.00%)
since 03/17/23

Most Recent Stories

More News
US Ambassador Adler visits Belgian Volition

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler, U.S....

VNRX : 0.8722 (-9.15%)
Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report summarising key themes from...

VNRX : 0.8722 (-9.15%)
Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison...

VNRX : 0.8722 (-9.15%)
Volition Hosts Key Opinion Leader Roundtable on Sepsis Management

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is hosting a Key Opinion Leader ("KOL") roundtable...

VNRX : 0.8722 (-9.15%)
VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June...

VNRX : 0.8722 (-9.15%)
VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, August 15 at 8.30 a.m. Eastern...

VNRX : 0.8722 (-9.15%)
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that the underwriters of its...

VNRX : 0.8722 (-9.15%)
VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today the closing of its previously...

VNRX : 0.8722 (-9.15%)
VolitionRx Limited Announces Pricing of $16.5 Million Underwritten Public Offering of Common Stock

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today the pricing of an...

VNRX : 0.8722 (-9.15%)
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has...

VNRX : 0.8722 (-9.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

3rd Resistance Point 1.0352
2nd Resistance Point 1.0026
1st Resistance Point 0.9374
Last Price 0.8722
1st Support Level 0.8396
2nd Support Level 0.8070
3rd Support Level 0.7418

See More

52-Week High 2.1000
Fibonacci 61.8% 1.5079
Fibonacci 50% 1.3250
Fibonacci 38.2% 1.1421
Last Price 0.8722
52-Week Low 0.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar